NasdaqGS:SYREBiotechs
A Look At Spyre Therapeutics (SYRE) Valuation After A Strong Recent Share Price Run
Recent performance context for Spyre Therapeutics (SYRE)
Spyre Therapeutics (SYRE) has drawn increased attention after a strong stock performance over the past 3 months and year to date, prompting investors to reassess what the current price implies.
See our latest analysis for Spyre Therapeutics.
The recent surge, including a 70.43% 90 day share price return and very large 3 year total shareholder return, points to strong momentum, even though the latest 1 day move was slightly weaker.
If...